High-precision Powder Weighing Automation Device JUNIOR

Our company will be exhibiting at the 42nd Medicinal Chemistry Symposium, which will be held from November 18 (Tuesday). Unchained Drugs will promote your company's digital transformation with our automated chemical research equipment. We look forward to seeing you at the venue! Exhibition details: ■ Dates: November 18 (Tuesday) to 20 (Thursday), 2025 *Corporate exhibits will be on the 18th and 19th for two days ■ Venue: Awagin Hall ■ Details: https://www.k-gakkai.jp/mcs2025/

**Webinar Overview** In recent times, as digital transformation (DX) progresses across many industrial sectors, there is a demand for the transformation of the compound optimization process (Design-Make-Test-Analyze Cycle) using digital technologies and automation in drug discovery research within pharmaceutical companies. In this presentation, we will introduce Daiichi Sankyo's efforts towards the automation of drug discovery chemistry and its integration with chemoinformatics/AI drug discovery, as well as share insights on automation in research settings. **Speaker** Yoshihiro Ogura, Senior Scientist, Daiichi Sankyo Co., Ltd.

Our company will be exhibiting at LADEC 2025 (Laboratory Automation Developers Conference). At our booth, you can see the automation equipment in operation. Please come visit us. Dates: September 25 (Thursday) - 26 (Friday), 2025 Venue: National Museum of Emerging Science and Innovation Details: https://laboratoryautomation.connpass.com/event/333560/

The SMPD division of Takeda Pharmaceutical Company has significantly evolved its high-throughput experimentation (HTE) and automation capabilities over the past few years. At the core of this evolution are the tools and devices from Unchained Labs, which offer high compatibility and enable an integrated comprehensive solution. Our ultimate goal is to build Self-Driving Labs (SDLs) that execute self-optimizing workflows utilizing AI and algorithms. Extensive parameter exploration is essential for process development and optimization, and iterative, data-driven SDLs demonstrate their true value, especially when combined with automated HTE synthesis platforms. In this webinar, we will present a vision for the future of fully automated optimization HTE workflows that can accommodate various applications in synthetic molecular pharmaceutical development. Additionally, we will delve into current success stories of existing hardware and software, as well as the challenges we face at this point through real-world examples.